| Typicality: | 0.428 |
| Saliency: | 0.342 |
| from the fda | 10 | location |
| in november | 5 | temporal |
| for a single crystal form | 4 | other |
| drug → receive → regulatory approval | 13 |
| drug → gain → regulatory approval | 13 |
| drug → received → regulatory approval | 5 |
| drug → be received → approval | 5 |
| drug → be received → regulatory approval | 3 |
| negative | neutral | positive |
| 0.124 | 0.606 | 0.270 |
| Raw frequency | 39 |
| Normalized frequency | 0.342 |
| Modifier score | 0.600 |
| Perplexity | 306.534 |